Hemicyanine‐Based Near‐Infrared Activatable Probes for Imaging and Diagnosis of Diseases

Molecular activatable probes with near‐infrared (NIR) fluorescence play a critical role in in vivo imaging of biomarkers for drug screening and disease diagnosis. With structural diversity and high fluorescence quantum yields, hemicyanine dyes have emerged as a versatile scaffold for the constructio...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie International Edition Vol. 60; no. 51; pp. 26454 - 26475
Main Authors Zeng, Ziling, Liew, Si Si, Wei, Xin, Pu, Kanyi
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 13.12.2021
EditionInternational ed. in English
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Molecular activatable probes with near‐infrared (NIR) fluorescence play a critical role in in vivo imaging of biomarkers for drug screening and disease diagnosis. With structural diversity and high fluorescence quantum yields, hemicyanine dyes have emerged as a versatile scaffold for the construction of activatable optical probes. This Review presents a survey of hemicyanine‐based NIR activatable probes (HNAPs) for in vivo imaging and early diagnosis of diseases. The molecular design principles of HNAPs towards activatable optical signaling against various biomarkers are discussed with a focus on their broad applications in the detection of diseases including inflammation, acute organ failure, skin diseases, intestinal diseases, and cancer. This progress not only proves the unique value of HNAPs in preclinical research but also highlights their high translational potential in clinical diagnosis. Near‐infrared fluorescent hemicyanines, known for their structural diversity, high fluorescence quantum yields, and good biocompatibility, are attractive scaffolds for the construction of activatable optical probes for disease diagnosis. This Review discusses the design strategies and sensing mechanisms of these probes, with an emphasis on their applications in early disease detection and imaging‐guided therapies.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.202107877